NDC 80425-0303-01 - Buspirone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0303
- Requested NDC
- 80425-0303-01
- Package NDCs from labels
- 80425-0303-1, 80425-0303-2, 80425-0303-3, 80425-0303-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Buspirone Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0303-1 | Buspirone Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 80425-0303-2 | Buspirone Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 80425-0303-3 | Buspirone Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0303 | BUSPIRONE HYDROCHLORIDE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8afd9b8-0885-2f0c-e053-6294a90a9c57.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0303-1 | EA - Each | 80425-0303 | f4913649-e1ba-42f9-8427-a607b54d7ddf | 1 | 2023-06-06 |
| 80425-0303-2 | EA - Each | 80425-0303 | 37cb4f00-cf48-48e7-87f2-e17af97a0001 | 1 | 2023-06-06 |
| 80425-0303-3 | EA - Each | 80425-0303 | 9453aa87-69d6-4b8b-9098-5a9978f87ac7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 068ee1a0-a77a-4803-bad9-18117d7fb358 | 2026-03-20 | Warnings, Adverse reactions | ANDA210907 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | REMEDYREPACK INC. | 8e0219e9-d305-4473-8229-aee0ee84caf6 | 2026-03-19 | Warnings, Adverse reactions | 866094 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 476f4f55-c6c1-4f39-950e-59236f499577 | 2026-03-18 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 7db10b76-4520-496e-b450-66a662cc95f6 | 2026-03-18 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 84621631-4c13-4147-ae3c-4ed30d4ebb37 | 2026-03-16 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | DIRECT RX | bae98d45-e192-56e3-e053-2a95a90aadc3 | 2026-03-05 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | AvPAK | b230197c-3d50-7874-e053-2a95a90af50f | 2026-03-04 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | b9aa144c-cb36-4069-9eaa-7c150298cdd7 | 2026-03-02 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Safecor Health, LLC | ebda05ee-d895-4636-bc28-d393e69c91b3 | 2026-02-20 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | ecdfd79e-7450-40ec-9561-cdda3a043990 | 2026-01-28 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | A-S Medication Solutions | 4d1ae09a-3ead-4604-8d13-590f41f63b96 | 2026-01-28 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 18ddef0b-1451-4bea-94fb-b6ec27f4744b | 2026-01-14 | Warnings, Adverse reactions | ANDA210907 866018 207LT9J9OC |
| BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | Direct_Rx | 8e9c0553-c994-f54a-e053-2a95a90a6fa3 | 2026-01-08 | Warnings, Adverse reactions | 866094 207LT9J9OC |
| Buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 427ad27e-6664-afee-e063-6394a90a1890 | 2026-01-08 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| busPIRone HCl | BUSPIRONE HYDROCHLORIDE | Advagen Pharma Ltd | 07a789a9-c9e8-4737-a56d-7d5405fe8100 | 2026-01-07 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 1521109d-8386-472f-9483-f1fe9f7ed152 | 2026-01-01 | Warnings, Adverse reactions | 866083 866090 866094 866018 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Northwind Health Company, LLC | f318ba7b-121f-2e4f-e053-2a95a90a60c5 | 2026-01-01 | Warnings, Adverse reactions | 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Northwind Health Company, LLC | d9de7cf1-c38d-8b3c-e053-2995a90aa26b | 2026-01-01 | Warnings, Adverse reactions | 866083 207LT9J9OC |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Northwind Health Company, LLC | ff02c7cb-f96a-4a3b-99a2-812cd78b345c | 2025-12-26 | Warnings, Adverse reactions | 866018 207LT9J9OC |
| buspirone hydrochloride | BUSPIRONE HYDROCHLORIDE | Zydus Lifesciences Limited | 1109dd63-6492-49b1-a383-3ab3a80cd6c7 | 2025-12-24 | 866083 866090 866094 866018 207LT9J9OC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.